Asthma Review and Management in Community Pharmacy

Not Applicable

• Conditions: Asthma Reviews; Respiratory - Asthma; Public Health - Health service research

• Registration Number: ACTRN12622001176752
• Lead Sponsor: Medical Research Institute of New Zealand

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-08-31
• Last Update Posted: 12 September 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

Participants are eligible to be included in the study only if all the following criteria apply:
1.Willing and able to provide written informed consent
2.Adults aged 18 to 65 years.
3.Physician diagnosis of asthma.
4.Have a prescription for Budesonide/formoterol 200µg/6µg (Symbicort® Turbuhaler) taken as required, per AIR algorithm step 1.
5.Access to a mobile phone and/or device with internet connectivity to complete remote assessments.
6.Willingness and ability to return for a follow up visit at week 12.
7.Willing to attend the study pharmacy for their asthma reviews throughout the length of the study.
8.Willing and able to comply with the study instructions.

Exclusion Criteria

Participants are excluded from the study if any of the following criteria apply:
1.Other chronic respiratory disease, such as COPD, Interstitial lung disease, etc.
2.Any acute or chronic medical condition that the investigator considers may impact the validity and reliability of the study results.
3.Current use of Budesonide/formoterol 200µg/6µg (Symbicort® Turbuhaler) as maintenance therapy per AIR algorithm step 2 or 3
4.Current use of any other inhaled medication for asthma.
5.Current use of theophylline, leukotriene receptor antagonist, sodium cromoglycate, nedocromil sodium or monoclonal antibody therapy for asthma.
6.Current use or use within the preceding 6 weeks of oral steroids.
7.Cognitive impairment preventing the participant from understanding the trial instructions or requires assistance in management of medications, complete questionnaires, or provide informed consent.
8.Active involvement in any clinical trial, or recent involvement in an interventional trial in the past 12 weeks.

Study & Design

• Study Type: Interventional
• Study Design: Not specified